We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Andersons Inc
ANDE
$2.21B
| $879K | ﹤0.01% |
12,850
-1,768
| -12% | -$128K |
2025 Q3
3 quarters
|
|
2752
iShares 1-3 Year International Treasury Bond ETF
ISHG
$848M
| $878K | ﹤0.01% |
11,821
+3,746
| +46% | +$282K |
2025 Q2
4 quarters
|
|
2753
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $877K | ﹤0.01% |
13,720
+1,033
| +8% | +$53.6K |
2025 Q2
4 quarters
|
|
2754
Pacira BioSciences
PCRX
$1.45B
| $877K | ﹤0.01% |
34,568
+7,415
| +27% | +$175K |
2024 Q2
8 quarters
|
|
2755
LXP Industrial Trust
LXP
$3.6B
| $876K | ﹤0.01% |
16,266
+2,154
| +15% | +$111K |
2022 Q4
14 quarters
|
|
2756
H2O America
HTO
$2.47B
| $876K | ﹤0.01% |
14,420
+4,023
| +39% | +$233K |
2022 Q1
17 quarters
|
|
2757
Invesco S&P SmallCap Momentum ETF
XSMO
$2.76B
| $876K | ﹤0.01% |
9,355
-582
| -6% | -$50.2K |
2025 Q3
3 quarters
|
|
2758
NIO
NIO
$8.24B
| $875K | ﹤0.01% |
172,924
-18,344
| -10% | -$107K |
2018 Q3
31 quarters
|
|
2759
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$466M
| $873K | ﹤0.01% |
18,894
+568
| +3% | +$25.2K |
2025 Q1
5 quarters
|
|
2760
Brookdale Senior Living
BKD
$2.41B
| $870K | ﹤0.01% |
54,055
-30,767
| -36% | -$418K |
2021 Q4
18 quarters
|
|
2761
Hornbeck Offshore Services, Inc.
HOS
$2.32B
| $869K | ﹤0.01% |
99,473
+48,779
| +96% | +$469K |
2024 Q3
7 quarters
|
|
2762
National Health Investors
NHI
$3.29B
| $869K | ﹤0.01% |
11,389
-3,289
| -22% | -$252K |
2025 Q1
5 quarters
|
|
2763
Franklin California Municipal Income ETF
FTCA
$543M
| $868K | ﹤0.01% |
117,010
+10,146
| +9% | +$74.6K |
2025 Q4
2 quarters
|
|
2764
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$491M
| $868K | ﹤0.01% |
28,121
+1,125
| +4% | +$33.5K |
2025 Q2
4 quarters
|
|
2765
MillerKnoll
MLKN
$1.45B
| $868K | ﹤0.01% |
42,406
+8,637
| +26% | +$138K |
2023 Q3
11 quarters
|
|
2766
Unitil
UTL
$1.01B
| $867K | ﹤0.01% |
16,448
+3,203
| +24% | +$166K |
2022 Q4
14 quarters
|
|
2767
Alerus Financial
ALRS
$804M
| $866K | ﹤0.01% |
27,856
+1,348
| +5% | +$37K |
2025 Q3
3 quarters
|
|
2768
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.37B
| $862K | ﹤0.01% |
39,530
+3,258
| +9% | +$71.1K |
2024 Q4
6 quarters
|
|
2769
Jackson Financial
JXN
$8.82B
| $861K | ﹤0.01% |
8,410
-2,034
| -19% | -$220K |
2023 Q3
11 quarters
|
|
2770
Goldman Sachs BDC
GSBD
$970M
| $860K | ﹤0.01% |
90,757
-56,463
| -38% | -$524K |
2019 Q3
27 quarters
|
|
2771
WisdomTree True Emerging Markets Fund
XC
$73.8M
| $860K | ﹤0.01% |
27,125
+127
| +0.5% | +$4.06K |
2023 Q3
11 quarters
|
|
2772
Trinity Industries
TRN
$2.03B
| $860K | ﹤0.01% |
24,858
+3,426
| +16% | +$116K |
2013 Q2
52 quarters
|
|
|
SA
2773
Seabridge Gold
SA
$2.63B
| $860K | ﹤0.01% |
33,394
+2,435
| +8% | +$73.2K |
2023 Q3
11 quarters
|
|
2774
Skydance Corporation
SKYD
$39.2B
| $857K | ﹤0.01% |
86,948
+1,388
| +2% | +$14.6K |
2025 Q3
3 quarters
|
|
2775
Shenandoah Telecom
SHEN
$573M
| $857K | ﹤0.01% |
56,811
+1,817
| +3% | +$28.6K |
2016 Q3
39 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.